Grace M - Search Results

1

A randomised trial to compare the pharmacokinetic, pharmacodynamic, and antiviral effects of peginterferon alfa-2b and peginterferon alfa-2a in patients with chronic hepatitis C (COMPARE).

Silva M, Poo J, Wagner F, Jackson M, Cutler D, Grace M, Bordens R, Cullen C, Harvey J, Laughlin M. Silva M, et al. Among authors: grace m. J Hepatol. 2006 Aug;45(2):204-13. doi: 10.1016/j.jhep.2006.03.008. Epub 2006 Apr 18. J Hepatol. 2006. PMID: 16780997 Clinical Trial.

2

Pegylating IFNs at his-34 improves the in vitro antiviral activity through the JAK/STAT pathway.

Grace MJ, Cutler D. Grace MJ, et al. Antivir Chem Chemother. 2004 Nov;15(6):287-97. doi: 10.1177/095632020401500601. Antivir Chem Chemother. 2004. PMID: 15646642 Free article. Review.

3

Pegylated IFNs for chronic hepatitis C: an update.

Grace MJ, Cutler DL, Bordens RW. Grace MJ, et al. Expert Opin Drug Deliv. 2005 Mar;2(2):219-26. doi: 10.1517/17425247.2.2.219. Expert Opin Drug Deliv. 2005. PMID: 16296749 Review.

4

Pegylated interferons for the treatment of chronic hepatitis C infection.

Luxon BA, Grace M, Brassard D, Bordens R. Luxon BA, et al. Among authors: grace m. Clin Ther. 2002 Sep;24(9):1363-83. doi: 10.1016/s0149-2918(02)80042-x. Clin Ther. 2002. PMID: 12380630 Review.

5

Structural and biological characterization of pegylated recombinant interferon alpha-2b and its therapeutic implications.

Wang YS, Youngster S, Grace M, Bausch J, Bordens R, Wyss DF. Wang YS, et al. Among authors: grace m. Adv Drug Deliv Rev. 2002 Jun 17;54(4):547-70. doi: 10.1016/s0169-409x(02)00027-3. Adv Drug Deliv Rev. 2002. PMID: 12052714 Review.

6

Structure, biology, and therapeutic implications of pegylated interferon alpha-2b.

Youngster S, Wang YS, Grace M, Bausch J, Bordens R, Wyss DF. Youngster S, et al. Among authors: grace m. Curr Pharm Des. 2002;8(24):2139-57. doi: 10.2174/1381612023393242. Curr Pharm Des. 2002. PMID: 12369859 Review.

7

Interferon-alpha as an immunotherapeutic protein.

Brassard DL, Grace MJ, Bordens RW. Brassard DL, et al. J Leukoc Biol. 2002 Apr;71(4):565-81. J Leukoc Biol. 2002. PMID: 11927642 Review.

8

Regulation of gene expression by pegylated IFN-alpha2b and IFN-alpha2b in human peripheral blood mononuclear cells.

Brassard DL, Delorenzo MM, Cox S, Leaman DW, Sun Y, Ding W, Gavor S, Spond J, Goodsaid F, Bordens R, Grace MJ. Brassard DL, et al. Among authors: grace mj. J Interferon Cytokine Res. 2004 Aug;24(8):455-69. doi: 10.1089/1079990041689638. J Interferon Cytokine Res. 2004. PMID: 15320959

9

Site of pegylation and polyethylene glycol molecule size attenuate interferon-alpha antiviral and antiproliferative activities through the JAK/STAT signaling pathway.

Grace MJ, Lee S, Bradshaw S, Chapman J, Spond J, Cox S, Delorenzo M, Brassard D, Wylie D, Cannon-Carlson S, Cullen C, Indelicato S, Voloch M, Bordens R. Grace MJ, et al. J Biol Chem. 2005 Feb 25;280(8):6327-36. doi: 10.1074/jbc.M412134200. Epub 2004 Dec 13. J Biol Chem. 2005. PMID: 15596441 Free article.

10

Structural and biologic characterization of pegylated recombinant IFN-alpha2b.

Grace M, Youngster S, Gitlin G, Sydor W, Xie L, Westreich L, Jacobs S, Brassard D, Bausch J, Bordens R. Grace M, et al. J Interferon Cytokine Res. 2001 Dec;21(12):1103-15. doi: 10.1089/107999001317205240. J Interferon Cytokine Res. 2001. PMID: 11798469

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

998 results

Search Page

Filters